Delivery Order SPE2DB25D3017-SPE2DB25FVJAK
- Not listed
- The Defense Logistics Agency awarded a $48.7 million delivery order to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) under a firm fixed-price contract type. This non-set-aside award was made on December 2, 2025, with an ultimate completion date of December 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the contract at its corporate office location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $40,764.88 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) on November 3, 2025, with an ultimate completion date of November 25, 2025. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where the contractor maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $21,516.67 to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) on January 15, 2026, with completion scheduled for February 6, 2026. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Mekinist 0.5 mg tablets (30-count units) under a firm fixed-price contract valued at $2,850.83. The award, issued on May 1, 2025, with completion targeted for May 22, 2025, represents a non-competitive delivery order placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,191.22 for 30 tablets of Mekinist 2 mg on December 23, 2025, with an ultimate completion date of January 15, 2026. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement of the oncology medication and contains no subcontractor information. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency has awarded a delivery order valued at $10,191.22 to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, scheduled for completion by January 21, 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in the same municipality. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,390.46 to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) with a completion date of February 9, 2026. The contract was awarded on January 16, 2026, using firm fixed-price pricing with no set-aside designation, indicating the award was made through full and open competition. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Mekinist 2 mg tablets (30-count units) with a contract ceiling value of $10,191.22. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open and competitive procurement. The ultimate completion date is January 5, 2026, and performance will take place at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Mekinist 2 mg tablets in quantities of 30 units. This is a firm fixed price contract with a ceiling value of $19,566.67 and an ultimate completion date of December 12, 2025. The contract carries no set-aside designation, indicating it was awarded through open competition. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $19,341.02 on July 22, 2025, for the supply of Mekinist 2 mg tablets (30-count units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 12, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVJAKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mekinist 2 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $9,670.51. The award, issued on May 8, 2025, with an ultimate completion date of May 30, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. The prime IDC enables the contractor to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The contract supports critical healthcare requirements for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through a flexible procurement mechanism designed to meet dynamic medical supply demands.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 5/8/25 |